We are pleased to announce the first call for proposals for the newly formed Mallinckrodt Pharmaceuticals partnership with Washington University. The goal of this agreement is to explore targets and pathways that lend themselves to drug discovery and, ultimately, to jointly discover new therapeutics. As part of the agreement, Washington University researchers will be able to apply for funding to support specific research projects that are likely to progress to new therapeutic options that are aligned with Mallinckrodt’s research priorities. If a project is selected, School of Medicine investigators would have access to Mallinckrodt’s resources, scientific equipment, and opportunities to collaborate with Mallinckrodt scientists, who have extensive expertise in drug development.
To introduce the partnership, a town hall meeting for Washington University faculty and staff led by visiting Mallinckrodt leadership will take place on:
Thursday, March 14, 2019
10 – 11 a.m.
Eric P. Newman Education Center, Room A
Please see the press release for more information on the program.